Science and Reports, 7 (1), 4275
Investors should carefully research the options to decide which spot on the spectrum feels right
This shortening is a well-known biomarker of aging and is associated with increased risks of cancer, cardiovascular disease, neurodegeneration, and metabolic disorders Blackburn et al., Nature , 2006
However, this is a US-based observational study, and newer GLP-1s are expensive treatments, meaning there may well be some important differences between the people taking GLP-1s and those not taking them that may not be fully controlled for
A Cardiovascular Mode of Action Trial of semaglutide is currently being conducted (NCT04032197)
Seven RCTs were double-blind and one was open label